Stay updated on Low Dose Sulindac & Eflornithine for FAP Clinical Trial
Sign up to get notified when there's something new on the Low Dose Sulindac & Eflornithine for FAP Clinical Trial page.

Latest updates to the Low Dose Sulindac & Eflornithine for FAP Clinical Trial page
- CheckyesterdayChange DetectedThe page now displays a 403 Forbidden error instead of the study record content, presenting a generic error screen and site footer.SummaryDifference18%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page now displays Revision: v3.6.6, replacing Revision: v3.6.5. This indicates a minor site version update to the page template rather than a change to the study information.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page's revision indicator was updated from v3.6.4 to v3.6.5, signaling a deployment of a new site version. No study content appears to be affected by this change.SummaryDifference0.1%

- Check58 days agoChange DetectedThe revision label was updated from v3.6.3 to v3.6.4. This indicates a newer system revision without changes to the study details or visible content.SummaryDifference0.1%

- Check80 days agoChange DetectedThe revision string on the page was updated from v3.6.2 to v3.6.3, signaling a small update to the page content or formatting rather than substantive changes to the study information.SummaryDifference0.1%

- Check87 days agoChange DetectedVersion tag updated from v3.6.0 to v3.6.2 on the page, signaling an update to the page template or backend. No substantive content edits are shown in the provided changes.SummaryDifference0.1%

Stay in the know with updates to Low Dose Sulindac & Eflornithine for FAP Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Low Dose Sulindac & Eflornithine for FAP Clinical Trial page.